MGI Pharma MOGN New patents, anti cancer Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MGI Pharma MOGN New patents, anti cancer

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (1810)	12/10/2007 12:03:41 PM
From: Biomaven	of 1826

Raised To Hold From Sell By Brean Murray That is too funny! Congrats to longs here. It's been a long journey from that ultimately disappointing mushroom trip in the early days. On a going-forward note, this merger should be good for SUPG - if Dacogen is any good then it would be a no-brainer for them to be acquired too. At very least there is a bit more marketing muscle to be had now. Likely SUPG is going to encounter a bit of weakness because of decent Vidaza results just released - may prove a decent buying opportunity here. (But obviously a lot will depend on results from ongoing Dacogen trial). Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next